Package Leaflet: Information for the Patient
Tamsulosin Kern Pharma 0.4 mg prolonged-release hard capsules EFG
tamsulosin hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The active substance of this medicine is tamsulosin. It is a selective antagonist of α1A/1D adrenergic receptors. It reduces the tension of the smooth muscles of the prostate and urethra, allowing urine to pass more easily through the urethra and facilitating urination. Additionally, it decreases the sensation of urgency.
This medicine is used in men for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (enlargement of the prostate gland). These symptoms include: difficulty urinating (weak urine stream), dripping, urgency, and frequent need to urinate both at night and during the day.
Do not take Tamsulosin Kern Pharma:
Warnings and precautions
Consult your doctor or pharmacist before starting to take tamsulosin:
Children and adolescents
Do not give this medicine to children or adolescents under 18 years of age because it does not work in this population.
Other medicines and Tamsulosin Kern Pharma
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Taking tamsulosin with other medicines of the same group (alpha-1 adrenergic receptor antagonists) may cause an undesirable drop in blood pressure.
It is especially important that you inform your doctor if you are being treated at the same time with medicines that can decrease the elimination of tamsulosin from the body (e.g., ketoconazole, erythromycin).
Taking Tamsulosin Kern Pharma with food and drinksTamsulosin should be taken after breakfast or the first meal of the day.
Pregnancy, breastfeeding, and fertility
This section is not relevant, as tamsulosin is intended only for male patients.
In men, abnormal ejaculation (alteration of ejaculation) has been reported. This means that semen is not released from the body through the urethra, but rather goes into the bladder (retrograde ejaculation) or that the ejaculated volume is reduced or nonexistent (ejaculatory insufficiency). This phenomenon is harmless.
Driving and using machines
There is no evidence that tamsulosin affects the ability to drive or use tools or machines. However, you should keep in mind that dizziness may occur, in which case you should not perform activities that require attention.
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is 1 capsule per day and should be taken after breakfast or after the first meal of the day. The capsule should be swallowed whole and not broken or chewed. Normally, tamsulosin is prescribed for long periods of time. The effects on the bladder and urination are maintained during long-term treatment with tamsulosin.
If you take more Tamsulosin Kern Pharma than you should
Taking too much tamsulosin may lead to an undesirable drop in blood pressure and an increase in heart rate, with a feeling of fainting.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Tamsulosin Kern Pharma
If you have forgotten to take tamsulosin as recommended, you can take your daily dose of tamsulosin later within the same day. In case you have missed the dose one day, you can simply continue taking your daily capsule as prescribed. Do not take a double dose to make up for forgotten doses.
If you stop taking Tamsulosin Kern Pharma
When treatment with tamsulosin is abandoned prematurely, your original symptoms may return. Therefore, take tamsulosin for the entire time your doctor prescribes it, even if your symptoms have disappeared. Always consult your doctor if you decide to stop treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking your medicine and seek medical help immediately if you have any of the following allergic reactions:
Common (may affect up to 1 in 10 patients):
Uncommon (may affect up to 1 in 100 patients):
Rare (may affect up to 1 in 1,000 patients):
Very rare (may affect up to 1 in 10,000 patients):
Frequency not known (cannot be estimated from the available data)
If you are going to undergo eye surgery due to cataracts and are already taking or have taken tamsulosin hydrochloride, the pupil may not dilate properly and the iris (the colored part of the eye) may become flaccid during the procedure (see section 2 "Warnings and precautions").
In addition to the side effects listed above,
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency's online platform: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the blister, bottle, and carton after "EXP". The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Tamsulosin Kern Pharma
Each capsule contains 0.4 mg of tamsulosin hydrochloride.
The other ingredients are:
Pellets: Methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30%*, microcrystalline cellulose, dibutyl sebacate, polysorbate 80 (E433).
Coating material:Methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30%*, dibutyl sebacate, polysorbate 80 (E433), hydrated silica.
Calcium stearate
Hard gelatin capsule:Red iron oxide (E172), titanium dioxide (E171), yellow iron oxide (E172), black iron oxide (E172), indigo carmine (E132), gelatin.
*The dispersion contains 0.7% sodium lauryl sulfate Ph.Eur / NF and 2.3% polysorbate 80 Ph.Eur / NF in solid substance, as emulsifiers.
Appearance of the product and pack contents
Tamsulosin Kern Pharma are hard capsules, approximately 15.6 - 16.2 mm in length, with an opaque orange body and an olive green cap. Tamsulosin Kern Pharma is available in PVC/PVdC-Al blisters or HDPE bottles, which are marketed in cardboard boxes.
The PVC/PVdC-aluminum blisters contain 10, 20, 30, 50, 90, or 100 capsules.
The precut unit-dose PVC/PVdC-aluminum blisters contain 10 x 1, 20 x 1, 30 x 1, 50 x 1, 90 x 1, or 100 x 1 capsules.
The HDPE bottles contain 30, 35, 50, 60, 90, 100, 112, or 200 capsules.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa – Barcelona
Spain
Manufacturer:
LABORATORIOS LICONSA, S.A.
Avda. Miralcampo, No. 7
Pol. Ind. Miralcampo, 19200
Azuqueca de Henares, Guadalajara
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Denmark - Tamsulosin "Liconsa", hårde kapsler med modificeret udløsning
France - TAMSULOSINE LICONSA LP 0,4 mg, gélule à libération prolongée
Romania - TAMSULOSIN LICONSA 0,4 mg caps
Spain – Tamsulosina Kern Pharma 0,4 mg cápsulas duras de liberación modificada EFG
Portugal – Tansulosina Pharmakern 0.4 mg cápsulas duras de libertação modificada
Ireland - Tamsulosin hydrochloride 0.4 mg modified release capsules, hard
Date of the last revision of this leaflet: May 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS): http://www.aemps.gob.es/.
The average price of TAMSULOSIN KERN PHARMA 0.4 mg PROLONGED-RELEASE HARD CAPSULES in October, 2025 is around 10.96 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.